Background. Despite the availability of guidelines for the evaluation of candidates for renal transplantation, variation in access to transplantation exists. This national survey investigates whether center variation exists in the assessment of patients for renal transplantation in the United Kingdom. Methods. An online survey, informed by qualitative interviews, was distributed to all UK renal centers. This survey examined center approaches to chronic kidney disease service provision, transplant recipient assessment, education provision, and waitlisting decision making processes. Center reevaluation policies for patients already listed and priorities for future development were also examined. Results. All 71 renal centers responded. Of these, 83% reviewed predialysis patients in a low clearance clinic. In 26% of the centers, transplantation was not discussed as a treatment option with all patients. Fourteen centers reported having a dedicated transplant assessment clinic, whereas 28% did not have a formal assessment protocol. Age was an exclusion criterion for listing in 3 centers, all of which had a cutoff at 75 years. Eighty-three percent of the centers excluded patients with a high body mass index. Cardiac investigations were risk-stratified in 90% of centers. Surgical involvement varied with 11% of centers listing patients without formal surgical review. There was no formal protocol in place to reevaluate listed patients in 62% of centers. Conclusions. There is wide variation in UK practice patterns for listing patients for renal transplantation, though its impact on access to transplantation is unclear. The extent to which center-specific and patient-specific factors affect access to transplantation requires further analysis in a prospective cohort of patients.
I t is widely regarded that for "suitable" patients with endstage renal failure, renal transplantation confers both better quality of life and life expectancy than dialysis and is the preferred modality of renal replacement therapy. [1] [2] [3] [4] In light of these benefits, achieving prompt and timely activation on the transplant waiting list is important not only because increasing length of time on dialysis adversely affects graft and patient survival 5 but also because organ allocation algorithms in many countries (including the United Kingdom) give priority to those who have spent greater time on the waiting list when allocating deceased donor kidneys. 6, 7 Thus, centers that achieve earlier listing for transplantation may provide an advantage for their patients compared with centers that take longer.
Various guidelines on the timing of referral for renal transplantation are available from professional organizations across the world. [8] [9] [10] Guidelines from the United States Organ Procurement and Transplantation Network Minority Affairs Committee state that the goal for referral should be that all potential candidates are referred for transplant at an estimated glomerular filtration rate above 20 mL/min per 1.73 m 2 to favor early transplantation and avoid the development of comorbidities associated with dialysis as well as allowing patients to accrue waiting time that increases their chance of being allocated a donor organ. 8 In comparison, the UK Renal Association guidelines recommend that patients with progressive deterioration in renal function suitable for transplantation should be placed on the national transplant list within 6 months of their anticipated dialysis start date and that preemptive transplantation should be the treatment of choice for all suitable patients whenever a living donor is available. 10 The term "suitable" used in these guidelines often poses a conundrum for clinicians as objective criteria to confirm suitability for transplantation are not clearly defined and hence are open to interpretation. To assist this process guidelines for the evaluation of candidates for renal transplantation have been published by the American Society of Transplantation, 11 the European Renal Association and European Society for Organ Transplantation, 12 the UK Renal Association, 10 the British Transplantation Society, 13 and Caring for Australasians with Renal Impairment.
14 Despite the availability of clinical guidelines, significant variations in the assessment practices among transplant centers have been reported in the United States as well as Europe. [15] [16] [17] To explore this further, we undertook a national survey as part of the NIHR funded Access to Transplantation and Transplant Outcome Measures (ATTOM) program to examine whether variation exists in the organization of renal services in listing patients and to describe center practices in the education and the evaluation of potential transplant recipients as well as exploring how decisions are made in the United Kingdom.
MATERIALS AND METHODS
A structured online and paper-based survey consisting of 96 questions was developed using the results of 2 qualitative studies carried out within the ATTOM program. 18, 19 Qualitative studies included 53 patients and 42 healthcare professionals, and explored patients' views and experiences of joining the transplant waiting list and staff members' experiences of listing patients for transplantation. Staff and patients were recruited from a purposive maximum variation sample of 9 renal units in the UK. Existing published literature was also reviewed and feedback sought and incorporated from a group of experts on the ATTOM steering group. Pilot faceto-face interviews with 4 clinicians were conducted using the first draft survey to guide revision to improve instrument face and content validity and usability before distribution.
The questionnaire was designed to establish the practice patterns of the unit relating to listing patients younger than 75 years for transplantation. Once finalised, both versions (online and paper-based) of the survey were sent to the lead physicians and surgeons of all 71 adult renal centers in the United Kingdom in January 2014. Clinicians were invited either to complete the survey personally or to nominate a representative within the unit to respond. It was specified that the respondent's answers should reflect current practice in the unit rather than individual preference.
Statistical analyses were performed using SAS version 9.3. Results for each question were expressed as a percentage of the total number of centers responding to the question. We identified several factors a priori as "exposure" variables and tested for associations of these categorical variables with care processes using Chi squared test or Mann Whitney test. Given the potential for multiple testing and false positives, we only report associations that were significant at P less than 0.01. To measure how much time renal staff were involved in transplantation listing, whole-time equivalent (WTE) time was asked. A WTE of 1.0 indicates that a person is equivalent to a whole-time worker, or 2 persons working half time.
RESULTS
A completed survey was received from all 71 (100%) adult centers in the United Kingdom, of which 23 were transplanting and 48 were nontransplanting renal centers. The reported roles of respondents were: clinical director (42.3%), consultant nephrologist (49.3%), consultant transplant surgeon (2.8%) and "other health professional" (5.6%). Forty centers (56.3%) completed the Web-based version and 31 centers (43.7%) the paper version of the survey. The responding centers had a total of 6699 patients active on the UK transplant waiting list at the end of 2012 and reported a national workforce involved in listing patients for transplantation which comprised of 488 WTE consultant nephrologists, 113 WTE transplant surgeons, 57 WTE associate specialists, 73 WTE transplant coordinators, and 75 WTE live kidney donor nurses. The median number of consultant nephrologists was significantly greater at transplanting centers (8.5; interquartile range [IQR], 8-11) compared with nontransplanting centers (4.5; IQR, 3-6), P < 0.001).
Chronic Kidney Disease Workforce and Organization
Almost 48% (47.9%, n = 34) of the centers reported seeing all predialysis patients in a dedicated low-clearance clinic (LCC), whereas 33.8% (n = 24) of centers used a LCC for some of their patients. The remaining 18.3% (n = 13) of centers did not have a designated LCC service. There was no significant difference between nontransplanting and transplanting centers in terms of the pattern of LCC utilization.
LCCs were mostly joint (consultant with nurse, 48.3%) or consultant-led (43.1%), with only 8.6% of centers having a nurse-led service. When LCCs were present, 30% of nontransplanting centers did not have a specified protocol for referral for transplantation compared with 11.1% of transplanting centers (P < 0.001).
Transplantation Education
Transplantation was discussed as a treatment option with all patients under the age of 75 years in 51 (71.8%) of centers, with other centers reporting a more selective policy. The decision not to discuss was made mostly by a consultant led multidisciplinary team (MDT) (55%) or solely by a consultant nephrologist (40%). Discussions regarding transplantation were led most often by a consultant nephrologist (64.8%), with nurses leading the discussion in 19.7%, transplant surgeons in 2.8% and 'other' healthcare professionals in 12.6% of centers. Despite reporting a wide range of educational delivery tools, education almost always took the form of a one-to-one consultation (98.6%) where patients were given literature to take home to read (91.5%).
Transplant Listing Pathway and Role of Transplant Surgeons
The clinical setting for transplant assessment varied, with 36.4% of centers using a LCC, 21.2% seeing patients in their usual chronic kidney disease (CKD) clinic and 19.7% using a specific transplant assessment clinic. The remaining 22.7% of centers reported a mix of "other" clinical settings. The use of specific transplant assessment clinics was similar in nontransplanting centers and transplanting centers, though the frequency varied widely, with clinics occurring monthly or less frequently in 55% of nontransplanting centers, as compared with 100% of transplanting centers running these clinics fortnightly or more frequently (P < 0.001). Overall, 88.2% (n = 63) of centers required all patients to be seen by a Transplant Surgeon before being listed; of the remaining 8 centers that did not require direct surgical review, 4 centers (1 transplanting and 3 nontransplanting) reported that all patients were discussed with a transplant surgeon, whereas 4 centers reported no surgical involvement in the decision to list for transplantation.
The Assessment Process
Nationally, 30% (n = 21) of the centers did not have a written transplant workup protocol for recipient assessment, which included 3 transplant centers. Figure 1 shows the frequency with which different investigations were used for the routine assessment of potential renal transplant recipients amongst the 71 centers. Three nontransplanting centers reported having an upper age limit of 75 years (above which patients were only considered in exceptional circumstances for transplantation) whereas all other centers (n = 68, 95.6%) did not report any age restrictions. In comparison, body mass index (BMI) was widely used as an exclusion criterion for listing patients, with 81.7% (n = 58) of centers excluding patients for transplantation based on BMI. The overall median upper BMI cutoff in these centers was 35 (IQR, 33.25-35), with 36 centers reporting an upper limit of 35, and 5 centers an upper limit of 40, whereas the remaining 17 centers stated a BMI limit between 33 and 30. The reasons stated for using BMI as an exclusion criterion are summarised in Table 1 . These did not differ between centers other than perceived increased cardiovascular risk, which appeared to be more of an issue for nontransplanting (52.5%) than transplanting centers (33.3%), P < 0.01.
All transplanting centers, and 87.5% (n = 65) of nontransplanting centers reported stratifying patients by risk when deciding which cardiac investigations to perform. Age (median, 50 years; IQR, 50-55) (88%), diabetes (97%), previous cardiovascular disease (91%), and an abnormal electrocardiogram (89%) were used to determine risk. Thirty-one (44%) centers conducted some form of "cardiac stress testing" even in low-risk patients, whereas significant variation was seen in the first-line investigation of choice for the assessment of coronary artery disease in high risk patients (Table 2) . If a coronary angiogram was deemed necessary for listing a low clearance patient, 5.6% (n = 4) of centers reported they would refrain from performing the test until patients were on dialysis to avoid precipitating the need for dialysis, with a further 74.6% stating they would 'sometimes' refrain from proceeding. Only 19.7% reported always proceeding.
Variation was also seen in screening for malignancies with 38% of centers reporting that screening for cancer such as breast, prostate, bladder and colorectal was part of the routine workup of transplant recipients, in addition to national screening programmes. In contrast, formal psychological or cognitive assessment of all potential recipients was only performed in 7.0% and 5.6% of centers respectively, with 13.1% of centers reporting no access to psychologist or counsellor services.
Decision Making
Overall 76.1% (n = 54) of centers used an MDT approach when listing patients for transplantation. This proportion was greater amongst transplanting centers where all but one center (95.7%) used an MDT, compared with 66.7% (n = 54) in nontransplanting centers. MDTs occurred more frequently in transplanting centers with a median of 4 meetings a month (IQR, 1.25-4) as compared to 2 a month (IQR, 1-4;P = 0.001) in nontransplanting centers.
If a patient was not deemed suitable for listing for deceased donor transplantation, 76.1% of centers said that they would consider listing them for living donor transplantation if a suitable donor was available. Living donor availability was generally seen as a positive driver for listing, alongside patient enthusiasm, whereas the majority of centers did not perceive socioeconomic factors, including employment status or level of patient education, as important when deciding whether to list patients for transplantation (Figure 2) . Once a decision After listing, only 38% of centers reported having a protocol in place to monitor patients activated on the transplant list with the majority of centers (53.5%) reviewing patient suitability annually. Significant variation existed in how centers undertook ongoing surveillance for cardiac disease in asymptomatic patients once listed as shown (Table 3 ). This was also highlighted in centers' responses to questions on improving listing, with 53 centers (74.6%) either agreeing or strongly agreeing with the need for having a national consensus on cardiac workup, and 52 centers (73.2%) also agreeing that there was a need for a consensus on the entire assessment workup process (Figure 3 ).
Intercenter Relationships and Future Development
Although 95% of centers reported having a positive relationship with a "good," "very good," or "excellent" relationship with their associated transplanting/nontransplanting centers, one third (n = 16) of nontransplanting centers felt that accessing an appointment at their affiliated transplanting center was a significant source of delay in listing patients.
Factors reported by centers to be most important in improving listing of patients for transplantation included: providing a better evidence base behind necessary assessment workup; improving the commissioning of transplant workup by funders of the service; and developing a national consensus on the workup of transplant recipients (Figure 3 ). If extra funding was available, centers stated they would use this to increase the number of transplant coordinators and livingdonor nurses, increasing the number of operation time slots for transplantation in trusts, and providing administrative support for allied health professionals involved in transplantation would likely improve overall listing and time to listing in their centers (Figure 4) .
DISCUSSION
This study provides the most extensive exploration to date of clinical practice patterns within renal centers in listing patients for renal transplantation in the United Kingdom and is the first to account for practice patterns in both transplanting and nontransplanting centers. It provides a comprehensive overview of the transplant-listing pathway including staffing levels, clinic arrangements, provision of patient education on transplantation, decision-making, recipient assessment, surgical review, criteria for listing, and the role of MDTs.
For a national population of 64.1 million, 20 the number of consultant transplant surgeons reported (1.76 per million population [pmp]) in this survey remains significantly lower than the 2 pmp recommended by the Royal College of Surgeons of England. 21 Indeed, the number of consultant nephrologists (7.61 pmp), transplant coordinators (1.14 pmp) and living-donor nurses (1.17 pmp) are all significantly lower than that recommended by the National Renal Workforce Planning Group and point toward an understaffed service. 21 Despite the UK Renal Association recommending that CKD patients prerenal replacement therapy should be managed in a dedicated clinic by a MDT, 22 this study also demonstrated wide variation in the utilization of LCCs nationally, with variation also seen in their implementation and entry criteria.
There are many studies, albeit small, which have shown that a dedicated predialysis clinic is associated with improved outcomes and reduced urgent initiation of dialysis. [23] [24] [25] [26] These clinics may provide focused opportunity to assess transplantation potential and more timely discussion of options including live donation and preemptive transplantation. Similarly, specific transplant-assessment clinics (used by a fifth of centers) enable joint assessment by physician and surgeon; whereas the evidence of their effectiveness is lacking they may be more efficient at transplant listing.
Irrespective of the type of CKD service in place, a broad range of educational methods were used across the UK, with one-to-one education being the main route. A significant proportion of centers (28%) did not discuss transplantation as a treatment option with all patients under the age of 75 years, and nearly 50% of patients who had had a decision made about them regarding transplantation were not informed of the decision made. This is of concern, as a patient-centered approach would require that all options are communicated to a patient and their family where possible. There may be exceptional circumstances where this may not always be feasible, but such instances would be expected to be less frequent than was reported in the present study.
Another important observation from this study was that some centers did not consider surgical review to be an absolute requirement for listing patients for transplantation. Eight centers listed without formal review, 4 of which cited no surgical involvement at all. The UK Renal Transplant Service specification stipulates that patients should undergo surgical assessment before being placed on the transplant list 27 ; however, it should be noted that in the United States, it is not uncommon to have only a subset of patients evaluated by transplant surgery in a face-to-face encounter. Instead, they selectively evaluate higher risk patients, for example, those with vascular disease.
Although in these centers it might be perceived that informed consent need not be taken by a surgeon and can instead be obtained by an experienced physician. The authors question whether without surgical input, patients can truly make an adequately informed choice and be involved in shared decision-making about transplantation and the associated surgical risks. Chronic understaffing described earlier and the belief that surgical evaluation of every patient before listing might reduce/delay access to transplant may partly explain why centers have adapted such practices, though its impact on outcome is not known.
Several national guidelines recommend that centers should have written criteria for acceptance of patients onto the waiting list, 10,28 yet nearly a third of centers reported not having a protocol, including 3 transplanting centers. The lack of standardization in these units could lead to variation in assessment, stereotyping, individual clinician bias and personal idiosyncrasies contributing to inequity. It was reassuring that the majority of the centers (95.6%) did not use chronological age per se as an exclusion criterion. This figure is higher than that seen in the United States, where 66% of centers reported having an upper age cutoff (in a similar study of transplanting centers), 15 and acknowledges the notion that age must not be used as a proxy for the assessment of individual need and suitability. It also highlights how clinicians are aware that chronological age can be very different to biological age in different individuals, and how assessment needs to be tailored on a case-by-case basis to avoid unwarranted age discrimination. In contrast to age, the majority of centers used BMI as an exclusion criterion, similar to findings from studies from the United States, 29 Canada, 30 and Europe, 31 with a wide upper BMI limit of 30 to 40. In the context of an increasingly obese population, such a broad range has the potential to cause variation in access to transplantation. Obese patients are certainly at an increased risk of technical difficulties and perioperative complications 32, 33 though evidence in favor of imposing a BMI limit on the basis of more hard end-points (patient and graft survival) is conflicting. [34] [35] [36] [37] [38] [39] A number of reports from nationwide databases, including the United States, Australia, and the Netherlands, 34, 37, 39 have shown decreased patient and graft survival in obese recipients, whereas others showed no differences in survival between obese and nonobese transplant recipients. 38 It is unclear in studies where an increase in risk was noted, how much would be mitigated once coexisting cardiovascular disease was accounted for. This raises the notion that if technically feasible, and cardiovascular disease has been ruled out, most patients should be considered for transplantation irrespective of their BMI.
As cardiovascular disease remains the main cause of death in transplant recipients, 40 it is unsurprising that most centers invest a great deal of time and resource in its investigation and management. This study showed that most centers stratify patients on their level of risk, though the choice of ensuing investigation varied greatly with no clear consensus irrespective of risk, from noninvasive functional tests to invasive angiography. This variation is likely due to a combination of factors including lack of evidence on superiority for any one investigation, as well as local cardiac service availability and experience. Centers also differed in their perception of risk associated with angiography in low-clearance patients. Overall, this variation has the potential for creating inequity, as centers adopting more intense screening protocols might impede waitlisting for patients with barriers to getting the tests completed.
Another important issue which needs mentioning is the cost implications of changing practice patterns, particularly at a time of receding budgets and rising concern over the cost and value of healthcare. Indeed, it is likely that individual center practices are in part, a consequence of local infrastructure and availability of service providers, and though instigating some changes may be relatively inexpensive, for example, introducing a written protocol, others, for example, introducing universal invasive cardiac screening for coronary artery disease, may require significant expenditure. Acknowledging this, before recommending significant changes to center practices, it is pertinent to demonstrate the medical efficacy and costeffectiveness of any proposed changes on access to transplantation which will also assist in ensuring they are long-lasting.
Limitations
Although this study received a 100% response rate across all parts of the UK and though the survey instrument was piloted and refined to enhance relevance, understandability, and usability; some limitations need to be acknowledged. The survey responses were self-reported by self-selecting renal staff, for example, the clinical lead for transplantation, and their responses will not necessarily reflect those of the broader consultant community. Likewise, as only a small proportion (2.8%) of respondents identified themselves as being a transplant surgeon this may have potentially biased the results due to the underrepresentation of surgical opinion among responders. Equally, we could not check the validity of responses garnered and some of these data were necessarily estimates and so should be regarded with caution. There may also have been a social desirability bias in the responses as respondents may have answered questions to put their center in a good light. Furthermore, most questions in the survey were multiple-choice questions that invited respondents to select the best possible answer out of the choices available. This approach necessarily limits their responses, although an option to select "other" was provided and the survey was designed after detailed qualitative interviews with patients and staff to identify core domains.
In conclusion, there is wide variation in UK practice patterns in listing patients for renal transplantation. Potential causes for this are likely to include variation in international guidelines and a lack of consensus in evaluating patients especially assessing their cardiovascular risk. [10] [11] [12] [13] [14] 28 Differing local population comorbidity and socioeconomic factors may also be playing a role alongside varying physician attitudes and beliefs toward transplant listing and risk assessment. 18 Future research should be directed at developing a national consensus on recipient workup and in understanding the utility of cardiovascular screening in potential transplant recipients, as well as gaining better long-term outcome data on the impact of obesity and age on transplantation.
There is also a need to understand the impact, if any, of this variation on access to transplantation. In the United Kingdom, as part of the NIHR funded ATTOM study, patient variables and the impact of center variables described in this study, will be further evaluated in a multilevel hierarchical model, in a prospective sample of incident dialysis patients recruited as part of the ATTOM Study.
